Ophthalmology Devices Market Report 2026

The ophthalmology devices market size has grown rapidly in recent years. It will grow from $56.61 billion in 2025 to $63.23 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to aging population increase, rising prevalence of cataract and glaucoma cases, expansion of hospital ophthalmology infrastructure, growth in eye care awareness programs, improvement in basic diagnostic ophthalmic equipment accessibility.

The ophthalmology devices market size is expected to see rapid growth in the next few years. It will grow to $99.22 billion by 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rising demand for minimally invasive eye surgeries, increasing healthcare expenditure on vision care, expansion of specialized eye care centers in emerging markets, growth in precision surgical tool innovation, rising adoption of advanced refractive correction procedures. Major trends in the forecast period include rising adoption of minimally invasive ophthalmic surgical systems and advanced phacoemulsification techniques, increasing preference for precision guided cataract and refractive surgery platforms, growth in laser based vision correction technologies, expansion of disposable ophthalmic surgical instruments to reduce infection risks, increasing demand for premium intraocular lens implantation and advanced lens customization solutions.

The increasing prevalence of eye disorders is expected to drive the growth of the ophthalmology devices market going forward. Eye disorders refer to medical conditions that impair vision or affect the structure and functioning of the eye, including glaucoma, cataracts, macular degeneration, and refractive errors. The rise in eye disorders is attributed to aging populations and the growing number of individuals exposed to risk factors such as chronic diseases and lifestyle-related causes. Ophthalmology devices support public health by providing diagnostic, monitoring, and treatment equipment that enables the early detection and management of eye conditions, preventing vision loss and improving the quality of care. For instance, in February 2026, according to the World Health Organization, a Switzerland-based international public health organization, at least 2.2 billion people globally were living with near or distance vision impairment, with nearly 1 billion cases preventable or yet to be addressed, highlighting the growing burden of eye disorders worldwide. Therefore, the increasing prevalence of eye disorders is driving the growth of the ophthalmology devices market.

Leading companies operating in the ophthalmology devices market are focusing on developing minimally invasive surgical devices, such as laser endoscopy ophthalmic systems, to improve surgical precision, minimize tissue trauma, and achieve more effective intraocular pressure reduction. Laser endoscopy ophthalmic systems combine endoscopic visualization with targeted laser therapy in an ab interno procedure, enabling surgeons to access and treat delicate intraocular structures with minimal disruption while improving procedural accuracy and workflow efficiency. For instance, in April 2025, BVI Medical, a US-based ophthalmic device company, launched Leos, its laser endoscopy ophthalmic system, which delivers high-quality endoscopic visualization of eye anatomy, integrates a novel ab interno laser procedure for lowering intraocular pressure, and provides an intuitive surgical workflow to improve precision and ease of use across a broad range of glaucoma types.

In January 2023, Bausch + Lomb Corporation, a Canada-based eye health company providing a broad range of ophthalmic surgical and vision care products, acquired AcuFocus, Inc. for an undisclosed amount. Through this acquisition, Bausch + Lomb aims to strengthen its surgical portfolio by integrating AcuFocus’s IC-8 Apthera small-aperture intraocular lens technology and expanding its offerings in premium cataract and extended depth-of-focus intraocular lens solutions. AcuFocus, Inc. is a US-based ophthalmic medical device company that develops and commercializes innovative small-aperture intraocular lenses for addressing cataracts and presbyopia in patients with corneal astigmatism.

Major companies operating in the ophthalmology devices market are EssilorLuxottica S. A., NIDEK Co. Ltd., Alcon Inc., HOYA Corporation, Bausch + Lomb Corporation, Canon Medical Systems Corporation, Topcon Corporation, Menicon Co. Ltd., STAAR Surgical Company, Glaukos Corporation, Lumibird Medical, BVI Medical Inc., Heidelberg Engineering GmbH, Carl Zeiss Meditec AG, Reichert Inc., Oertli Instrumente AG, Konan Medical USA Inc., Sterimedix Ltd, Haag Streit Group, Ziemer Ophthalmic Systems AG, Katena Products Inc., Marco Ophthalmic Inc.

North America was the largest region in the ophthalmology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the ophthalmology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ophthalmology devices consists of sales of optical coherence tomography (OCT) systems, slit lamps, fundus cameras, tonometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.